Trump order set to stop supply of HIV, malaria drugs to poor countries: Sources

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2025-01-29 12:03 GMT | Update On 2025-01-29 12:03 GMT

Bengaluru: The Trump administration has moved to cease the supply of lifesaving medicines for HIV, malaria and tuberculosis, and medical supplies for newborn babies, in countries supported by United States Agency for International Development (USAID), according to a memo reviewed by Reuters.

Sources revealed that on Tuesday, contractors and partners who work with the USAID started receiving directives instructing them to halt operations immediately. The move is part of a wider freeze on U.S. aid and funding put in place since Trump took office on Jan. 20, while programmes are reviewed.

One such memo went to Chemonics, a large U.S. consulting firm which works with USAID on the supply of medicines for a range of conditions worldwide.

The memo covers the firm's work on HIV, malaria and tuberculosis as well as contraception and maternal and child health supplies, one USAID source and one former USAID official told Reuters.

"This is catastrophic," said Atul Gawande, former head of global health at USAID who left the agency this month. "Donated drug supplies keeping 20 million people living with HIV alive. That stops today."

Chemonics and USAID did not immediately respond to Reuters' requests for comment.

Interruptions in treatment for diseases mean that patients risk getting sick, as well as, in the case of HIV in particular, transmitting the virus to others. It also means drug-resistant strains may emerge, Gawande said.

He said other partners had also received notices that meant they would be unable to deliver medicines to clinics even if they had them in stock, or open the clinics if they are funded by the U.S.

That includes organisations working with 6.5 million orphans and vulnerable children with HIV in 23 countries, he said.

Trump ordered a 90-day pause in foreign development assistance on Jan. 20, the day he took the oath of office, pending assessments of efficiencies and consistency with U.S. foreign policy.

His administration has also put on leave about 60 senior career officials at the USAID, sources familiar with the matter told Reuters on Monday.

The administration's actions threaten billions of dollars of life-saving aid from the world's largest single donor. In fiscal year 2023, the U.S. disbursed $72 billion in assistance. It provided 42 per cent of all humanitarian aid tracked by the United Nations in 2024.

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Trump order set to stop supply of HIV, malaria drugs to poor countries: Sources

Similar News

USFDA Reappoints Vinay Prasad to Top Medical and Scientific Role

B Pharmacy Graduate Held for Operating Unauthorized Clinic in Hyderabad

No Generics for AbbVie's Rinvoq Until 2037, Analysts See Multi-Billion Dollar Boost

Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026

Chennai Court Acquits 2 After Alleged Nitravet Haul Found to Be Paracetamol

USFDA warns pharma cos to remove misleading ads

Intas Pharma appoints Dr Ajay Kumar Handa as new Executive Vice President - RnD

Sun Pharma Halol facility gets OAI status from USFDA